KIMSKrishna Institute of Medical Sciences Ltd
Krishna Institute of Medical Sciences to merge subsidiary KIMS Hospitals
- Mergers & acquisitions
- Healthcare

Krishna Institute of Medical Sciences (NSE: KIMS) has approved a scheme of amalgamation of its wholly owned subsidiary KIMS Hospitals Private Limited into the holding company, it said in a filing on 04 Nov 2026. The board approved the scheme on 04 Nov 2026 after a recommendation from the Audit Committee. The filing says there is no cash consideration and no new shares are issued under the scheme.
Key highlights
- Board approval: 04 Nov 2026, on Audit Committee recommendation
- Cash consideration: none; no new shares issued under the scheme
- Transferee turnover as on 31 Mar 2026: ₹1,701.50 crore
- Transferee PAT as on 31 Mar 2026: ₹260.70 crore
The amalgamation in numbers
| Item | Detail |
|---|---|
| Transferor | KIMS Hospitals Private Limited, a wholly owned subsidiary |
| Transferee | Krishna Institute of Medical Sciences Limited, the holding company |
| Approved by board | 04 Nov 2026, on Audit Committee recommendation |
| Consideration | No cash consideration and no new shares issued |
| Transferor paid-up capital | 6,59,99,999 equity shares of ₹10 each, amounting to ₹65,99,99,990 |
| Transferee paid-up capital | 42,00,06,484 equity shares of ₹2 each, amounting to ₹84,00,12,968 |
| Transferor turnover and PAT, 31 Mar 2026 | Nil |
| Transferee turnover, 31 Mar 2026 | ₹1,701.50 crore |
| Transferee PAT, 31 Mar 2026 | ₹260.70 crore |
| Related party transaction | Yes; the company states it is exempted as a transaction between a holding company and its wholly owned subsidiary |
The structure and the stated rationale
The scheme folds KIMS Hospitals Private Limited into its parent, Krishna Institute of Medical Sciences Limited, and both companies are engaged in healthcare activities, according to the filing.
The company states the rationale as simplifying the group corporate structure and eliminating multiple legal entities, achieving operational and administrative efficiencies by pooling resources and management functions, and optimising utilisation of assets, reducing statutory compliances and cutting costs. It also lists strengthening the consolidated financial position, enabling focused management and unified decision-making, and enhancing shareholder value.
The figures the filing gives for the two companies
The parent reported turnover of ₹1,701.50 crore and PAT of ₹260.70 crore on the same date, a PAT margin of 15.3%.
The parent's paid-up capital is 42,00,06,484 equity shares of ₹2 each, while the subsidiary's is 6,59,99,999 equity shares of ₹10 each. Since the subsidiary is wholly owned, the filing states that no share exchange ratio applies and the parent's shareholding pattern remains unchanged. In its filings of 29 Oct 2026 the company also reported stake acquisitions, but the merger filing does not link them to this scheme.
What the merger means for Krishna Institute of Medical Sciences' shareholders
For shareholders of the listed parent, the filing states that the shareholding pattern remains unchanged and that no new shares are issued, because the subsidiary is already wholly owned. The scheme changes the group structure rather than the share count.
Not stated: the effective date, the timeline for approvals from regulators, shareholders and the court, and the financial impact of the merger on the parent's results. The filing sets no dated next step.
Filed with NSE on . Reference: Original filing (PDF)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.

